By Scott Gottlieb (Original source AEI)
“Senior citizens are facing increasing and often significant burdens from rising out-of-pocket costs on drugs that they need to improve their health while many observers worry about the long run stability of the Part D program. As part of the Prescription Drug Pricing Reduction Act (PDPRA), the Senate Finance Committee is considering two significant reforms to the Medicare Part D program aimed at reducing overall program outlays and beneficiary out-of-pocket spending. Most notably, the proposal would substantially redesign the structure of the Part D benefit to encourage more efficient management of drug spending and reduce incentives that encourage rapid growth of list prices. In addition, it would establish mandatory rebates in Medicare Part D if list prices on drugs grow faster than the rate of inflation (as measured by CPI-U) to reduce enrollee out-of-pocket spending.”
Click here to see more
Edward Fishman’s Chokepoints Longlisted for FT Award
Edward Fishman’s Chokepoints Longlisted for the Financial Times Best Business Book of the Year 2025 Edward Fishman’s Chokepoints: How the Global Economy Became a Weapon…
Thought Leader: Edward Fishman
Peter Zeihan on Trump’s Economic Shifts
Today, we’ll be turning our attention towards the economic moves that the Trump admin made while I was away. Intel was partially nationalized (10% government…
Thought Leader: Peter Zeihan
Dr. Sanjay Gupta: What Ultra-Marathoner Learned From His Chronic Pain
You may feel pain in the body, but it really begins in the brain. To explain, Dr. Sanjay Gupta sits down at 92nd Street Y…
Thought Leader: Sanjay Gupta
